12-102852875-C-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP3PP4PM5PM3_Strong
This summary comes from the ClinGen Evidence Repository: The PAH c.782G>C (p.Arg261Pro) variant has been reported in multiple affected individuals (PMID:26666653, Bh4 deficiency not ruled out, PP4). It has been detected with 5 known pathogenic variants (PM3_S). It is absent from ExAC/gnomAD. Computational evidence supports a deleterious effect. Also, p.R261Q is interpreted as pathogenic. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_S, PM2, PM5, PP4, PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA229759/MONDO:0009861/006
Frequency
Consequence
NM_000277.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAH | NM_000277.3 | c.782G>C | p.Arg261Pro | missense_variant | Exon 7 of 13 | ENST00000553106.6 | NP_000268.1 | |
PAH | NM_001354304.2 | c.782G>C | p.Arg261Pro | missense_variant | Exon 8 of 14 | NP_001341233.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAH | ENST00000553106.6 | c.782G>C | p.Arg261Pro | missense_variant | Exon 7 of 13 | 1 | NM_000277.3 | ENSP00000448059.1 | ||
PAH | ENST00000307000.7 | c.767G>C | p.Arg256Pro | missense_variant | Exon 8 of 14 | 5 | ENSP00000303500.2 | |||
PAH | ENST00000549247.6 | n.541G>C | non_coding_transcript_exon_variant | Exon 1 of 6 | 2 | |||||
PAH | ENST00000635477.1 | c.-59G>C | upstream_gene_variant | 5 | ENSP00000489230.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727230
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Phenylketonuria Pathogenic:4
- -
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg261 amino acid residue in PAH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 2574153, 16765994). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects PAH function (PMID: 27620137). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PAH protein function. ClinVar contains an entry for this variant (Variation ID: 102832). This missense change has been observed in individuals with phenylketonuria (PMID: 32668217). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 261 of the PAH protein (p.Arg261Pro). -
Variant summary: PAH c.782G>C (p.Arg261Pro) results in a non-conservative amino acid change located in the Aromatic amino acid hydroxylase, C-terminal domain (IPR019774) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251358 control chromosomes. c.782G>C has been reported in the literature in multiple individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria), including as a compound heterozygous phenotype (e.g. Jeannesson-Thivisol_2015). These data indicate that the variant is likely to be associated with disease. A different variant affecting the same codon has been classified as pathogenic by our lab (c.782G>A, p.Arg261Gln), supporting the critical relevance of codon 261 to PAH protein function. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in ~10% of normal enzyme activity in vitro (e.g. Trunzo_2016). The following publications have been ascertained in the context of this evaluation (PMID: 26666653, 27620137). ClinVar contains an entry for this variant (Variation ID: 102832). Based on the evidence outlined above, the variant was classified as pathogenic. -
The PAH c.782G>C (p.Arg261Pro) variant has been reported in multiple affected individuals (PMID: 26666653, Bh4 deficiency not ruled out, PP4). It has been detected with 5 known pathogenic variants (PM3_S). It is absent from ExAC/gnomAD. Computational evidence supports a deleterious effect. Also, p.R261Q is interpreted as pathogenic. In summary, this variant meets criteria to be classified as pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM3_S, PM2, PM5, PP4, PP3. -
not provided Pathogenic:2Other:1
- -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at